CD4⁺CD8⁺ double-positive T cells in immune disorders and cancer: Prospects and hurdles in immunotherapy

Medicine and Dentistry

• Malignant Neoplasm 100%
• T Cell 100%
• Immune Disorder 100%
• CD8 Antigen 100%
• Immunotherapy 100%
• Immune Response 10%
• Innate Immunity 10%
• Breast Cancer 10%
• Secretion (Process) 10%
• Cytokine 10%
• Metastatic Carcinoma 10%
• Advanced Cancer 10%
• Prevalence 10%
• Virus Infection 10%
• Cell Population 10%
• Cytotoxic T-Cell 10%
• Lymphatic Tissue 10%
• Melanoma 10%
• Hepatocellular Carcinoma 10%
• Cellular Immunity 10%
• T-Helper Cell 10%
• Adaptive Immunity 10%
• Gamma Interferon 10%
• Interleukin 10 10%
• Developmental Stage 10%
• Transforming Growth Factor Beta 10%
• Cutaneous T Cell Lymphoma 10%
• Diseases 10%
• Nodular Lymphocyte Predominant Hodgkin's Lymphoma 10%

Immunology and Microbiology

• CD4 100%
• CD8 100%
• Immunotherapy 100%
• T Cell 100%
• Immune System Disorders 100%
• Viral Disease 9%
• Innate Immune System 9%
• Adoptive Immunity 9%
• T-Helper Cell 9%
• Cytotoxic T-Cell 9%
• Adaptive Immune System 9%
• Lymphoid Tissue 9%
• Immune Disorder 9%
• Immune Response 9%
• Cell Population 9%
• Secretion (Process) 9%
• Prevalence 9%
• Interleukin 10 9%
• Cytokine 9%
• Developmental Stage 9%
• Interferon Gamma 9%
• Transforming Growth Factor Beta 9%
• Lymphocyte 9%